1 of 6
- Purdue bankruptcy due to opioid crisis. Pharmaceutical Purdue Pharma filed for bankruptcy to save itself from more than 2,600 lawsuits.
- The preliminary agreement proposed by the pharmaceutical company does not adequately hold either the family or the company for their role in creating an addiction crisis that has killed more than 400,000 Americans in the last two decades.
- Filing for bankruptcy may not prevent the pharmacist or its owners, the Sackler family, other legal problems.
Purdue bankruptcy. The manufacturer of the analgesic OxyContin, the pharmaceutical house Purdue Pharma, and its owners lamented the opioid crisis in the United States, although without assuming responsibility for the situation, while Sunday night the company declared bankruptcy to save itself from numerous lawsuits, within an operation to resolve with an agreement about 2,600 lawsuits against the firm, most of local and state governments.
"As families across the United States, we feel a deep compassion for the victims of the opioid crisis," Sackler family members said in a statement, describing the preliminary agreement as a "historic step to provide key resources that address a tragic public health situation ”.
However, filing for bankruptcy may not prevent the pharmacist or the Sacklers from other legal problems.
Around half of the states and lawyers representing at least 1,000 local governments have accepted the principle of agreement, which according to the company could mean between 10,000 and 20,000 million dollars over several years, including at least 3,000 million of dollars from the Sackler family. The agreement also indicates that the company would go to managers and grant its creditors the future benefits of Oxycontin and developing drugs.
IT IS TREND:
Filed as: Purdue bankruptcy